RJA
DPLO
Raymond James & Associates’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-29,159
| Closed | -$169K | – | 3646 |
|
|
2019
Q1 | $169K | Buy |
+29,159
| New | +$169K | ﹤0.01% | 3267 |
|
|
2018
Q3 | – | Sell |
-9,553
| Closed | -$244K | – | 3606 |
|
|
2018
Q2 | $244K | Buy |
+9,553
| New | +$244K | ﹤0.01% | 3126 |
|
|
2018
Q1 | – | Sell |
-11,861
| Closed | -$238K | – | 3476 |
|
|
2017
Q4 | $238K | Sell |
11,861
-25,163
| -68% | -$505K | ﹤0.01% | 2941 |
|
|
2017
Q3 | $767K | Buy |
37,024
+1,800
| +5% | +$37.3K | ﹤0.01% | 2248 |
|
|
2017
Q2 | $521K | Sell |
35,224
-2,171
| -6% | -$32.1K | ﹤0.01% | 2384 |
|
|
2017
Q1 | $596K | Buy |
37,395
+1,935
| +5% | +$30.8K | ﹤0.01% | 2276 |
|
|
2016
Q4 | $447K | Buy |
35,460
+5,435
| +18% | +$68.5K | ﹤0.01% | 2393 |
|
|
2016
Q3 | $841K | Sell |
30,025
-1,327
| -4% | -$37.2K | ﹤0.01% | 1981 |
|
|
2016
Q2 | $1.1M | Sell |
31,352
-4,720
| -13% | -$165K | ﹤0.01% | 1688 |
|
|
2016
Q1 | $988K | Buy |
36,072
+9,833
| +37% | +$269K | ﹤0.01% | 1669 |
|
|
2015
Q4 | $898K | Sell |
26,239
-51
| -0.2% | -$1.75K | ﹤0.01% | 1693 |
|
|
2015
Q3 | $755K | Buy |
26,290
+9,790
| +59% | +$281K | ﹤0.01% | 1742 |
|
|
2015
Q2 | $738K | Buy |
+16,500
| New | +$738K | ﹤0.01% | 1869 |
|